BCLS Acquisition Corp. (NASDAQ: BLSA) announced this afternoon that due to its inability to complete a business combination, it intends to dissolve and liquidate its trust.
As of the close of business on October 26, BCLS’s publicly held Class A ordinary shares will be deemed cancelled and will represent only the right to receive the per-share redemption price of $10.03 within ten business days.
As of September 30, the balance of BLSA’s trust account was $144,329,573, including the $579,573 in interest and dividend income, excess of cash over $143,750,000, the funds deposited into the trust. In accordance with the terms of the trust agreement, BCLS expects to retain $100,000 of the interest and dividend income from the trust to pay dissolution expenses.
Although BCLS’s management team did not provide commentary on the liquidation, current market dynamics and ongoing economic uncertainty have impacted many SPACs forcing them to liquidate. BCLS now becomes the 42nd SPAC to announce a liquidation this year.
The SPAC, which had 24 months on its timeline to complete a business combination, announced the pricing of its $125 million IPO in October 2020. BCLS aimed to combine with a life sciences target with innovative biotech, pharmaceutical or diagnostics technology.
Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...
M3-Brigade V (NASDAQ:MBAV) has entered into a definitive agreement to combine with crypto treasury firm ReserveOne, assembling about $1 billion in equity funding. ReserveOne is setting up a diversified Bitcoin and digital asset treasury with a portion of its investments going towards blockchain infrastructure and venture raises. The combined company is expected to trade on...
At the SPAC of Dawn As the SPAC market has warmed in 2025, only 21 of the 70 SPACs (30%) that have IPO’d thus far have overfunded their trusts to draw in investors and none of these funded to more than 101%. By contrast, 87% of 2023 SPACs were overfunded – some to as high...
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...